Interviews

Mike Agostino, RPh, President, National Association of Specialty Pharmacy, reflects on how the organization advances the specialty pharmacy industry through their annual meeting.

Matt Gillin, Chief Executive Officer, Relay Network, speaks about takeaways specialty pharmacies can learn from other businesses in terms of customer communications, adoption, and behavior change.

Joy Gilbert, Vice President, Operations, US Bioservices, a part of AmerisourceBergen, speaks to the difficulties that face manufacturers who are launching a novel specialty product.

Christopher W. Kennedy, MSM, Chief Operating Officer, Heritage Biologics, discusses the importance of value-based care for the specialty pharmacy industry.

John Giannouris, vice president, Specialty Pharmacy Services, ValueCentric, discusses the features specialty pharmaceutical manufacturers look for when choosing a data aggregator.

Ron Lanton III, Esq., President, True North Political Solutions, touches on some policies that are changing and may support biosimilar development.

Brandon Newman, PharmD, CSP, Program Director, Vanderbilt Specialty Pharmacy, talks about why the Certified Specialty Pharmacist distinction is significant.

Achilles Alon, PharmD, RPh, Director of Specialty Pharmacy, Co-owner of ACE-Rx Specialty Pharmacy, tackles some of the challenges in starting a new specialty pharmacy.

Kyle Truitt, Co-Founder, Turning Point, LLC, discusses the High-Performing Specialty Pharmacy Association.

Joy Gilbert, Vice President, Operations, US Bioservices, a part of AmerisourceBergen, discusses the importance of new orphan drug approvals for patients.

Matt Gillin, Chief Executive Officer, Relay Network, talks about why mobile health is important for patient care.

Amanda Walker, CPXP, BSN, RN, Senior Vice President, Patient Experience, Heritage Biologics, discusses RXPX, the Pharmacy Patient Experience Certification.

Ron Lanton III, Esq., President, True North Political Solutions, discusses the significant differences between biosimilars and generic drugs.

Brandon Newman, PharmD, CSP, Program Director, Vanderbilt Specialty Pharmacy, discusses why clinical outcomes data are important for specialty pharmacies.

Achilles Alon, PharmD, RPh, Director of Specialty Pharmacy, Co-owner of ACE-Rx Specialty Pharmacy, discusses what drove him to join the world of specialty pharmacy and the most rewarding part of it.

Joy Gilbert, Vice President, Operations, US Bioservices, a part of AmerisourceBergen, talks about the impact orphan drugs have had on the specialty pharmaceutical industry.

John Giannouris, vice president, Specialty Pharmacy Services, ValueCentric, speaks about data analytics and specialty pharmacy.

Matt Gillin, Chief Executive Officer, Relay Network, discusses what a crucial role technology plays in medication adherence.

Marc O’Connor, chief operating officer, Curant Health discusses the role specialty pharmacists play in chronic disease management.

Jon Gavras, MD, chief medical officer at Prime Therapeutics, analyzes the benefits of pharmacy benefit tools for patients with private and public insurance.

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses how patient data can be used to drive down drug costs.

Grant Knowles, PharmD, vice president, Business Development, Ardon Health, discusses the role digital health may play in patient care.

Marc O’Connor, chief operating officer at Curant Health, discusses how pharmacists can improve adherence among patients with chronic diseases.

Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, discusses potential opportunities for specialty pharmacies as technology continues to evolve.

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses which drugs are expected to dominate the market in 2017.

Jon Gavras, MD, chief medical officer at Prime Therapeutics, lists the strategies pharmacy benefit managers use to reduce spending on opioids.

Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses the importance of a quick turnaround from patient referral to acceptance.

Marc O’Connor, chief operating officer at Curant Health, explains ways patient care models can reduce costs.

Joel Wright, chief executive officer, Alliance Rx Walgreens Prime discusses how stakeholder alliances benefit patients.

In this video, Tripp Logan, PharmD, explains how pharmacists can establish solid relationships with other providers to maximize the management of patients' diabetes.